Drug Abuse Research Today is a free monthly online journal that collates and summarizes the latest research about Drug Abuse, including details on psychology, rehabilitation, consequences, treatment.

Volume 2 (2006), Issue 2 (February)

1. Club drug use among youths in treatment for substance abuse.
   Am J Addict, 15(1): 94-9. [Abstract] [Full-text]
2. The effects of alcohol and drug dependence on the course of depression.
   Am J Addict, 15(1): 71-5. [Abstract] [Full-text]
3. Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and delavirdine.
   Am J Addict, 15(1): 23-34. [Abstract] [Full-text]
4. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities.
   Drug Alcohol Depend, 81(3): 221-9. [Abstract] [Full-text]
5. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
   Drug Alcohol Depend, 81(3): 323-6. [Abstract] [Full-text]
6. High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities.
   Drug Alcohol Depend, 81(3): 259-65. [Abstract] [Full-text]
7. A consistent attentional bias for drug-related material in active cocaine users across word and picture versions of the emotional Stroop task.
   Drug Alcohol Depend, 81(3): 251-7. [Abstract] [Full-text]
8. Cocaine increases actin cycling: effects in the reinstatement model of drug seeking.
   J Neurosci, 26(5): 1579-87. [Abstract] [Full-text]
9. Reducing the risk of HIV infection associated with illicit drug use.
   Pediatrics, 117(2): 566-71. [Abstract] [Full-text]
10. Health services use and growth patterns among older siblings of infants with prenatal drug exposure.
    Appl Nurs Res, 19(1): 10-5. [Abstract] [Full-text]
11. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Arch Gen Psychiatry, 63(2): 201-8. [Abstract] [Full-text]
12. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Public Health Nurs, 23(1): 11-9. [Abstract] [Full-text]
13. Condom attitudes and behaviors among injection drug users participating in California syringe exchange programs.
    AIDS Behav, 9(4): 423-32. [Abstract] [Full-text]
14. Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs.
    AIDS Behav, 9(4): 495-504. [Abstract] [Full-text]
15. Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, Bordering Nepal, Bhutan, and Bangladesh.
    Subst Use Misuse, 41(3): 341-52. [Abstract] [Full-text]
16. Hospitalization due to alcohol and drug abuse in first- and second-generation immigrants: a follow-up study in Sweden.
    Subst Use Misuse, 41(3): 283-96. [Abstract] [Full-text]
17. Definition and outcome of a curriculum to prevent disordered eating and body-shaping drug use.
    J Sch Health, 76(2): 67-73. [Abstract] [Full-text]
18. Orbitofrontal cortex, decision-making and drug addiction.
    Trends Neurosci, 29(2): 116-24. [Abstract] [Full-text]
19. Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder.
    Biol Psychiatry, 59(3): 258-64. [Abstract] [Full-text]
20. Coexisting psychiatric disorders in a New Zealand outpatient alcohol and other drug clinical population.
    Aust N Z J Psychiatry, 40(2): 164-70. [Abstract] [Full-text]
21. Illicit drug use and dependence in a New Zealand birth cohort.
    Aust N Z J Psychiatry, 40(2): 156-63. [Abstract] [Full-text]
22. Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers.
    Psychopharmacology (Berl), 184(3): 391-400. [Abstract] [Full-text]
23. Nicotine as a typical drug of abuse in experimental animals and humans.
    Psychopharmacology (Berl), 184(3): 367-81. [Abstract] [Full-text]
24. Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats.
    Psychopharmacology (Berl), 184(3): 417-25. [Abstract] [Full-text]
25. NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice.
    Neuropsychopharmacology, 31(3): 572-84. [Abstract] [Full-text]
26. HIV and HCV testing for young drug users in Rhode Island.
    J Adolesc Health, 38(3): 302-4. [Abstract] [Full-text]
27. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review.
    Clin Psychol Rev, 26(2): 162-78. [Abstract] [Full-text]
28. Relapse to alcohol and other drug use in treated adolescents: review and reconsideration of relapse as a change point in clinical course.
    Clin Psychol Rev, 26(2): 149-61. [Abstract] [Full-text]
29. Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial.
    Vaccine, 24(10): 1670-9. [Abstract] [Full-text]
30. Gender and HIV risk behavior among intravenous drug users in Sichuan Province, China.
    Soc Sci Med, 62(7): 1672-84. [Abstract] [Full-text]
31. Overdoses among friends: drug users are willing to administer naloxone to others.
    J Subst Abuse Treat, 30(2): 129-33. [Abstract] [Full-text]
32. How do treatment repeaters use the drug treatment system? An analysis of injection drug users in Massachusetts.
    J Subst Abuse Treat, 30(2): 121-8. [Abstract] [Full-text]
33. Differences in motivation, coping style, and self-efficacy among incarcerated male and female drug users.
    J Subst Abuse Treat, 30(2): 113-20. [Abstract] [Full-text]
34. Drug dependence enviromics: job strain in the work environment and risk of becoming drug-dependent.
    Am J Epidemiol, 163(5): 404-11. [Abstract] [Full-text]
35. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.
    Am J Epidemiol, 163(5): 412-20. [Abstract] [Full-text]
36. Predictors of retention in an alcohol, tobacco, and other drug prevention study.
    Eval Rev, 30(2): 209-22. [Abstract] [Full-text]
37. Personality traits and the development of nicotine, alcohol, and illicit drug disorders: prospective links from adolescence to young adulthood.
    J Abnorm Psychol, 115(1): 26-39. [Abstract] [Full-text]
38. Rate of elimination of Wolbachia pipientis by doxycycline in vitro increases following drug withdrawal.
    Antimicrob Agents Chemother, 50(3): 922-7. [Abstract] [Full-text]
39. Prevalence of problematic and injecting drug use for Drug Action Team areas in England.
    J Public Health (Oxf), 28(1): 3-9. [Abstract] [Full-text]
40. The relationship between self-reported sexual orientation and behavior in a sample of middle-aged male injection drug users.
    Arch Sex Behav, 35(1): 67-74. [Abstract] [Full-text]
41. Drug consumption and violence in female work Zapallal--Lima/Peru.
    Rev Lat Am Enfermagem, 13: 1185-93. [Abstract] [Full-text]
42. Women living in a drug (and violence) context--the maternal role.
    Rev Lat Am Enfermagem, 13: 1142-7. [Abstract] [Full-text]
43. International nursing leadership related to the drugs phenomenon: a case study of the partnership experience between the Inter-American Drug Abuse Control Commission (CICAD) and the University of Alberta--Faculty of Nursing.
    Rev Lat Am Enfermagem, 13: 1102-17. [Abstract] [Full-text]
44. International Research Capacity-Building Programs for Nurses to Study the Drug Phenomenon in Latin America: challenges and perspectives.
    Rev Lat Am Enfermagem, 13: 1095-101. [Abstract] [Full-text]
45. Deaths from drug overdose and toxicity in Turkey: 1997-2001.
    Am J Forensic Med Pathol, 27(1): 50-4. [Abstract] [Full-text]
46. Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors.
    Epilepsia, 47(2): 375-9. [Abstract] [Full-text]
47. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
    Addiction, 101(3): 433-40. [Abstract] [Full-text]
48. Effectiveness of drug and alcohol counselling during methadone treatment: content, frequency, and duration of counselling and association with substance use outcomes.
    Addiction, 101(3): 404-12. [Abstract] [Full-text]
49. How much can treatment reduce national drug problems?
    Addiction, 101(3): 341-7. [Abstract] [Full-text]
50. What drug policies cost: estimating drug policy expenditures in Sweden, 2002: work in progress.
    Addiction, 101(3): 330-8. [Abstract] [Full-text]
51. What drug policies cost: drug policy spending in the Netherlands in 2003.
    Addiction, 101(3): 323-9. [Abstract] [Full-text]
52. What drug policies cost: estimating government drug policy expenditures.
    Addiction, 101(3): 315-22. [Abstract] [Full-text]
53. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales.
    Vaccine, 24(13): 2377-86. [Abstract] [Full-text]
54. Illicit drug use and injuries: A review of emergency room studies.
    Drug Alcohol Depend, 82(1): 1-9. [Abstract] [Full-text]
55. Risk profile of individuals who provide assistance with illicit drug injections.
    Drug Alcohol Depend, 82(1): 41-6. [Abstract] [Full-text]

© 2005-2008 Drug Abuse Research Today. All Rights Reserved.